Coronary angiography and stenting are two of the most fundamental and frequently performed procedures in the Cath Lab Market. A coronary angiogram is a diagnostic procedure that uses a special contrast dye and X-rays to visualize the coronary arteries. It is the gold standard for identifying the location and severity of blockages, which are often the cause of chest pain or heart attacks. This initial step is critical for determining the appropriate course of treatment.

If a significant blockage is found, a therapeutic intervention such as stenting is often performed immediately. Stenting is a minimally invasive procedure where a small, expandable metal mesh tube, known as a stent, is placed in the blocked artery to hold it open. This restores proper blood flow to the heart muscle. Over the years, stents have evolved from bare-metal to drug-eluting, which release medication to prevent the artery from re-narrowing, significantly improving long-term patient outcomes.

The high volume of these procedures makes them a central pillar of the Cath Lab Market. As the prevalence of coronary artery disease continues to rise, the demand for both diagnostic angiography and therapeutic stenting will remain strong. The continuous innovation in stent technology and the refinement of procedural techniques ensure that these interventions will continue to be a cornerstone of modern cardiovascular care.

FAQ

Q: What is the difference between coronary angiography and stenting? A: Coronary angiography is a diagnostic procedure to find blockages, while stenting is a therapeutic procedure to open a blocked artery.

Q: How has stent technology improved over time? A: Stents have evolved from bare-metal to drug-eluting stents, which release medication to prevent re-blockages, leading to better long-term outcomes.